Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Adult Immune Responses to Vaccine”

200 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 200 results

Early research (Phase 1)UnknownNCT05007275
What this trial is testing

Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers

Who this might be right for
Covid19SARS-CoV-2 Infection
Imperial College London 28
Early research (Phase 1)Study completedNCT00574600
What this trial is testing

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT01511250
What this trial is testing

Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years

Who this might be right for
Healthy
Takeda 360
Post-approval studies (Phase 4)Looking for participantsNCT07177417
What this trial is testing

Characterizing the Human Airway Immune Response to FluMist Vaccination

Who this might be right for
Healthy Young AdultsInfluenza VaccinesInfluenza Vaccine Response
Washington University School of Medicine 30
Early research (Phase 1)Study completedNCT03186781
What this trial is testing

Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT00919178
What this trial is testing

Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus

Who this might be right for
Dengue Shock SyndromeDengue Hemorrhagic Fever
National Institute of Allergy and Infectious Diseases (NIAID) 70
Large-scale testing (Phase 3)Study completedNCT00474487
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
Novartis Vaccines 2,831
Not applicableStudy completedNCT01765413
What this trial is testing

Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines

Who this might be right for
Healthy
University of Surrey 48
Early research (Phase 1)Study completedNCT06573281
What this trial is testing

A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 213
Early research (Phase 1)Study completedNCT00347672
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 42
Early research (Phase 1)Study completedNCT00955006
What this trial is testing

Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 17
Early research (Phase 1)Looking for participantsNCT07111078
What this trial is testing

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

Who this might be right for
Influenza PreventionPandemic Influenza Prevention
National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Study completedNCT04566276
What this trial is testing

ChulaCov19 Vaccine in Healthy Adults

Who this might be right for
COVID-19 VaccineSafety Issues
Chulalongkorn University 192
Early research (Phase 1)Study completedNCT00083603
What this trial is testing

Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 150
Testing effectiveness (Phase 2)Study completedNCT02425241
What this trial is testing

Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination

Who this might be right for
HIV
University College, London 41
Large-scale testing (Phase 3)Study completedNCT01277042
What this trial is testing

Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years)

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,212
Early research (Phase 1)Study completedNCT00124007
What this trial is testing

Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 114
Early research (Phase 1)Study completedNCT01783977
What this trial is testing

Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 143
Early research (Phase 1)Study completedNCT00027261
What this trial is testing

Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT06620003
What this trial is testing

A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Marburg Virus Vaccine in Healthy Adults

Who this might be right for
Marburg Virus Disease
Albert B. Sabin Vaccine Institute 200
Next Page